Skip to main content
TipRanks
Go Ultimate75% OFF

Heron Therapeutics (AXD2) Q1 2021 Earnings Report

4 Followers

DE:AXD2 Q1 2021 EPS Results

Actual EPS
-EUR 0.53
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
-EUR 0.52

DE:AXD2 Q1 2021 Revenue Results

Actual Revenue
EUR 18.16M
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
-21.19%

Earnings Announcement Details

Quarter
Q1 2021
Date
05/10/2021
Time
Before Open
Conference Call
Monday, May 10, 2021
DE:AXD2 Upcoming Earnings

Heron Therapeutics's next earnings date is estimated for March 4, 2027, based on past reporting schedules.

Q1 2021 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q1 2021 Earnings Slide Deck

No slide deck is available for this earnings event.

Q1 2021 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:AXD2 Earnings History

DE:AXD2 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 04, 20272026 (Q4)-0.03--0.02――
Nov 09, 20262026 (Q3)-0.02-0.03-0.0970.00% (+0.06)
Aug 10, 20262026 (Q2)-0.00-0.03-0.02-50.00% (-0.01)
May 11, 20262026 (Q1)-0.02-0.040.01-500.00% (-0.05)
Feb 26, 20262025 (Q4)-0.02-0.020.02-200.00% (-0.04)
Nov 04, 20252025 (Q3)-0.01-0.09-0.03-233.33% (-0.06)
Aug 08, 20252025 (Q2)-0.01-0.02-0.0566.67% (+0.04)
May 06, 20252025 (Q1)-0.010.01-0.02150.00% (+0.03)
Feb 27, 20252024 (Q4)-0.030.02-0.06128.57% (+0.08)
Nov 12, 20242024 (Q3)-0.03-0.03-0.1582.35% (+0.13)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed